All News
Turkey ApprovalMarch 2, 2026651
Lecanemab Receives Approval in Turkey: Early Stage Alzheimer Treatment
Amyloid plaque-clearing antibody therapy lecanemab has been approved by TITCK for early-stage Alzheimer's disease.
Noron baglantilari ve beyin yapisi
First in Turkey
Lecanemab slows Alzheimer's progression by clearing amyloid plaques in the brain. Phase 3 trials showed 27% reduction in cognitive decline.